What Happened?
San Francisco, CA-based Vir Biotechnology Appointed Kevin Anglim as Associate Director, Compensation
About the Company
Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world`s most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
About the Person
Kevin Anglim is Associate Director, Compensation at Vir Biotechnology. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile